How to transfer my Topamax prescription to California

If you’re struggling with binge eating disorder (BED), you might be wondering whether you can receive treatment through telehealth—especially if accessing traditional in-person care feels overwhelming or impossible. The short answer is yes, you absolutely can. In fact, telehealth has become one of the most accessible and effective ways to get evidence-based medication treatment for BED, and the legal framework in 2026 supports this option more robustly than ever before.

This comprehensive guide will walk you through everything you need to know: which medications are available via telehealth, how the laws work in your state, what to expect during your virtual appointment, and how to find safe, legitimate care.

Understanding Binge Eating Disorder and Why Medication Matters

Binge eating disorder is the most common eating disorder in the United States, affecting millions of people who experience recurrent episodes of consuming large amounts of food while feeling out of control. Unlike bulimia, BED doesn’t involve purging behaviors, but it can lead to significant physical health complications, emotional distress, and diminished quality of life.

According to DSM-5 criteria, BED is diagnosed when someone experiences binge eating episodes at least once a week for three months, accompanied by feelings of distress and lack of control. These episodes aren’t triggered by hunger—they’re often driven by emotional factors, stress, or underlying neurobiological differences in impulse control and reward processing.

While therapy (particularly cognitive-behavioral therapy) remains the gold standard for BED treatment, medication can be a valuable tool, especially when:

• Therapy alone hasn’t been sufficient
• You need help managing intense cravings or urges
• Co-occurring conditions like depression or anxiety are present
• You’re working to break the binge cycle while building healthier coping strategies

The challenge? Many people with BED face barriers to in-person treatment: limited specialists in their area, long wait times, transportation issues, work schedules, or simply the stigma that makes walking into a clinic feel impossible. Telehealth removes many of these barriers, connecting you with licensed providers who can evaluate, diagnose, and prescribe medication—all from the privacy of your home.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Which Medications Are Available for BED via Telehealth?

When it comes to telehealth prescribing for binge eating disorder, the legal landscape depends heavily on whether a medication is classified as a controlled substance under federal law.

The Controlled vs. Non-Controlled Distinction

The only FDA-approved medication specifically for BED is lisdexamfetamine (Vyvanse), a controlled stimulant (Schedule II). While effective, Vyvanse faces stricter telehealth regulations. Under current DEA rules (extended through December 31, 2026), prescribing controlled substances via telehealth requires either a prior in-person visit or special temporary flexibilities that many providers are hesitant to rely on given regulatory uncertainty.

However, two widely-used, evidence-supported medications for BED are NOT controlled substances:

1. Topiramate (Topamax)

• What it is: Originally approved for seizures and migraine prevention, topiramate is commonly prescribed off-label for BED
• How it helps: Research suggests it may reduce binge frequency and support weight management by affecting neurotransmitters involved in appetite regulation and impulse control
• Telehealth accessibility: ✅ Fully accessible nationwide via telehealth with no federal restrictions
• Important considerations:
• Not safe during pregnancy (associated with birth defects like cleft palate)
• Requires gradual titration and monitoring for cognitive side effects
• Should be tapered slowly if discontinued to prevent seizure risk

2. Bupropion (Wellbutrin)

• What it is: An atypical antidepressant also used for smoking cessation, prescribed off-label for BED
• How it helps: May help reduce binge frequency by modulating dopamine and norepinephrine, potentially addressing underlying depression or emotional eating triggers
• Telehealth accessibility: ✅ Fully accessible nationwide via telehealth with no federal restrictions
• Important considerations:
• Contraindicated in people with current or past bulimia/anorexia (increased seizure risk)
• Not recommended for those with seizure disorders
• Carries a black box warning for increased suicidal thoughts in people under 25
• Should not be combined with alcohol

Because neither topiramate nor bupropion are controlled substances, they fall completely outside the scope of the Ryan Haight Act and DEA telehealth restrictions. This means providers licensed in your state can prescribe them via telehealth following the same standards they would for any other non-controlled medication.

Federal Telehealth Laws: What You Need to Know in 2026

The regulatory landscape for telehealth prescribing has evolved significantly since the COVID-19 pandemic. Here’s where things stand as of early 2026:

For Non-Controlled Medications (Like Topamax and Wellbutrin)

There are NO federal in-person requirements. The Ryan Haight Act, which regulates online prescribing, only applies to controlled substances (Schedule II-V drugs like stimulants, opioids, and benzodiazepines). For non-controlled medications, federal law simply requires that the prescriber:

• Is licensed in the state where you’re located
• Establishes an appropriate provider-patient relationship
• Follows the same standard of care as in-person treatment

This has been true since before the pandemic and remains permanently in effect.

For Controlled Substances

The DEA’s COVID-era flexibilities—which allowed providers to prescribe controlled substances via telehealth without a prior in-person visit—have been extended through December 31, 2026. However, the DEA is expected to implement permanent rules that will likely require in-person evaluations before prescribing most controlled substances via telehealth.

For BED patients, this means: While your provider might not be able to prescribe Vyvanse (the FDA-approved BED medication) via telehealth without seeing you in person, they can absolutely prescribe topiramate or bupropion with no such restrictions.

State-by-State Telehealth Rules: Does Your State Allow It?

While federal law sets the baseline, individual states can add their own requirements. The good news? The vast majority of states have made telehealth prescribing for non-controlled medications either completely unrestricted or minimally restricted.

States with NO In-Person Requirement for Non-Controlled Medications

These states allow providers to conduct a telehealth evaluation and prescribe medications like Topamax or Wellbutrin without ever requiring an in-person visit:

• California – Telehealth exams (even asynchronous ones) count as establishing a provider-patient relationship if they meet the standard of care
• New York – No in-person requirement for non-controlled substances (2025 rules only added requirements for controlled meds)
• Texas – Permits teleprescribing for non-controlled medications with appropriate video evaluation
• Florida – No in-person requirement for non-controlled drugs
• Delaware – Full telehealth prescribing allowed under state Telehealth Act
• Michigan – Standard telehealth allowed with no special restrictions
• Wisconsin – No in-person requirement for non-controlled prescriptions
• South Carolina – Allows telehealth evaluation to substitute for in-person exam if appropriate

States with Periodic In-Person Follow-Up Requirements

A handful of states require patients on ongoing telehealth treatment to have periodic in-person visits—but these can often be with any healthcare provider (not necessarily the prescriber):

• Alabama – If you have more than 4 telehealth visits for the same condition within 12 months, you must have an in-person evaluation within that year (can be with a collaborating provider)
• Georgia – Requires an attempt at annual in-person follow-up for ongoing telemedicine care
• New Hampshire – For controlled substances, requires annual in-person follow-up (non-controlled medications have no such requirement)

Important note: Even in these states, you can start treatment via telehealth. The in-person requirement only applies to long-term, ongoing care—and is often satisfied by seeing your regular primary care doctor for an annual physical.

States Where Nurse Practitioners Can Prescribe Independently

Whether your telehealth provider is a physician (MD/DO) or a nurse practitioner (NP) may matter depending on your state. As of 2026, 34 states plus DC grant NPs full practice authority, meaning they can evaluate and prescribe medications independently without physician oversight. These include:

• California, New York, Delaware, New Hampshire, Michigan, Wisconsin, and many others

In states like Texas, Florida, Georgia, and Alabama, NPs must work under a collaborative agreement with a physician. This doesn’t prevent them from prescribing BED medications—it’s simply a behind-the-scenes regulatory requirement. You’ll still receive the same quality of care.

Bottom line: Regardless of your state, licensed prescribers (MDs, DOs, NPs, or PAs) working through legitimate telehealth platforms can prescribe topiramate or bupropion for BED as long as they’re licensed in your state and follow appropriate clinical standards.

What to Expect During Your Telehealth BED Evaluation

Understanding the evaluation process can help you feel more prepared and confident. Here’s what a legitimate telehealth BED assessment typically involves:

Initial Consultation (30-45 minutes)

Your provider will conduct a comprehensive evaluation that covers:

Eating Pattern Assessment

• Frequency and duration of binge episodes
• Amount and types of food consumed during binges
• Feelings of loss of control
• Emotional triggers and circumstances
• Absence of compensatory behaviors (to rule out bulimia)

Medical History

• Current medications and supplements
• Past mental health diagnoses (especially depression, anxiety, ADHD)
• History of other eating disorders
• Seizure history or neurological conditions
• Pregnancy status and contraception plans
• Substance use (particularly alcohol)

DSM-5 Criteria VerificationYour provider will confirm you meet the diagnostic criteria:

• Recurrent binge eating episodes (at least weekly for 3 months)
• Episodes characterized by eating large amounts in a discrete period
• Sense of lack of control during episodes
• Episodes associated with at least 3 of these: eating rapidly, eating until uncomfortably full, eating when not hungry, eating alone due to embarrassment, feeling disgusted or guilty afterward
• Marked distress about binge eating
• No regular compensatory behaviors

Safety Screening

• Contraindications for proposed medications
• Suicidal ideation assessment (especially important for bupropion, which carries a black box warning)
• Ability to safely participate in telehealth treatment

Identity and Location Verification

Don’t be surprised when your provider asks you to confirm your identity and current location at the beginning of the visit. This isn’t distrust—it’s a legal requirement in many states. Providers must verify:

• You are who you say you are
• You’re physically located in a state where they’re licensed
• Your pharmacy is located in an appropriate jurisdiction

Documentation and Consent

Before prescribing, your provider will:

• Obtain informed consent for telehealth treatment
• Explain the off-label use of medication (since Topamax and Wellbutrin aren’t FDA-approved specifically for BED)
• Discuss risks, benefits, and alternatives
• Document that you meet diagnostic criteria and that an appropriate evaluation was conducted

Treatment Plan Development

If medication is appropriate, your provider will:

• Recommend a specific medication and explain why
• Discuss starting dose and titration schedule
• Set expectations for how long it takes to see effects
• Establish a follow-up schedule
• Discuss complementary treatments (therapy, nutrition counseling)
• Send your prescription electronically to your chosen pharmacy

Are You a Good Candidate for Telehealth BED Treatment?

While telehealth dramatically expands access, it’s not right for everyone. Here are factors that determine whether online treatment is appropriate:

You’re Likely a Good Candidate If:

✅ You meet DSM-5 criteria for binge eating disorder
✅ You’re medically stable without urgent complications
✅ You can safely take the proposed medication (no contraindications)
✅ You have reliable internet access and privacy for video appointments
✅ You’re committed to regular follow-up appointments
✅ You’re open to combining medication with therapy or other supports
✅ You can access a pharmacy to fill prescriptions

You May Need In-Person Care If:

❌ You have a current or recent history of bulimia or anorexia nervosa (bupropion is contraindicated)
❌ You have uncontrolled epilepsy or seizure disorder (both medications can lower seizure threshold)
❌ You’re pregnant or planning pregnancy (topiramate carries significant fetal risks)
❌ You have severe medical instability requiring physical examination or urgent intervention
❌ You’re experiencing active suicidal ideation requiring immediate crisis intervention
❌ You need controlled medications like Vyvanse (tighter telehealth restrictions apply)
❌ You’ve had adverse reactions to both topiramate and bupropion in the past

Your telehealth provider will carefully screen for these factors during your evaluation. If they determine you need in-person care, they should provide appropriate referrals rather than simply denying treatment.

How Klarity Health Makes BED Treatment Accessible

At Klarity Health, we’ve designed our telehealth platform specifically to remove barriers to mental health and eating disorder treatment. Here’s what sets us apart:

Provider Availability When You Need It

Unlike traditional clinics with months-long wait lists, Klarity connects you with licensed providers—often within 24-48 hours of your initial request. We understand that when you’re ready to seek help for BED, waiting months can mean the difference between starting recovery and remaining stuck in the cycle.

Transparent, Affordable Pricing

We accept both insurance and cash pay, with upfront, transparent pricing—no surprise bills or hidden fees. For patients paying out-of-pocket, we offer competitive rates that are often more affordable than traditional in-office visits with specialists.

Comprehensive, Not Just Prescriptions

While medication can be an important tool, Klarity’s approach to BED treatment is holistic. Our providers discuss therapy options, nutritional strategies, and lifestyle modifications alongside any medication recommendations. We can help coordinate care with therapists, dietitians, and your primary care provider.

Licensed Providers in Your State

Every Klarity provider is fully licensed in the state where you’re located, ensuring compliance with all state telehealth regulations. Whether you’re in California or Alabama, Texas or New York, we connect you with a provider who understands both the clinical aspects of BED and the legal requirements of your jurisdiction.

Long-Term Support

BED treatment isn’t a one-time prescription—it requires ongoing monitoring, dose adjustments, and support. Klarity makes follow-up appointments easy to schedule, with messaging capabilities between visits if you have questions or concerns.

Safety and Quality: How to Identify Legitimate Telehealth Providers

The telehealth boom has unfortunately attracted some bad actors. Here’s how to ensure you’re working with a reputable provider:

Red Flags to Avoid

🚩 Promises prescriptions before evaluation – No legitimate provider can guarantee medication before assessing you
🚩 Extremely brief consultations – If your ‘evaluation’ is 5 minutes of yes/no questions, run
🚩 No discussion of alternatives – Ethical providers discuss therapy, lifestyle changes, and multiple medication options
🚩 Selling medication directly – Prescriptions should go through licensed pharmacies, not the telehealth company’s ‘own supply’
🚩 No licensed provider involvement – AI questionnaires can assist, but a real licensed professional must evaluate and prescribe
🚩 Pressure tactics – ‘Limited time offer on prescriptions’ is a huge red flag
🚩 Unwillingness to provide provider credentials – You have a right to know your provider’s license number and verify it

Green Flags of Quality Care

✅ Comprehensive intake process – Detailed medical history, diagnostic assessment, and safety screening
✅ Clear consent process – Explanation of telehealth limitations, medication risks, and off-label use
✅ Multiple treatment options discussed – Not just medication, but therapy, support groups, and self-help strategies
✅ Regular follow-up schedule – Plan for ongoing monitoring and dose adjustments
✅ Professional documentation – After-visit summaries, treatment plans, and medication guides provided
✅ Accessible customer support – Easy way to contact the service with questions between appointments
✅ Transparent about limitations – Honest about what telehealth can and cannot treat safely

Questions to Ask Your Telehealth Provider

• ‘Are you licensed in my state? What’s your license number?’
• ‘How often will we meet for follow-up appointments?’
• ‘What happens if I have a medication side effect or crisis between appointments?’
• ‘Do you coordinate with therapists or other providers?’
• ‘What’s your approach if this medication doesn’t work for me?’
• ‘Can you provide references from professional organizations or certifying boards?’

Understanding Off-Label Medication Use for BED

Many patients are concerned when they learn their provider is recommending a medication that isn’t FDA-approved specifically for binge eating disorder. This is completely normal and legal.

What ‘Off-Label’ Means

Off-label prescribing means using an FDA-approved medication for a condition or in a manner not explicitly approved by the FDA. This is:

• Legal and extremely common (studies suggest up to 20% of prescriptions are off-label)
• Often supported by clinical research and medical guidelines
• A standard part of medical practice when evidence suggests benefit

For BED, both topiramate and bupropion have been studied in clinical trials showing potential benefit for reducing binge frequency, even though neither has gone through the full FDA approval process specifically for this indication.

Why Not Just Use the FDA-Approved Drug?

Vyvanse (lisdexamfetamine) is FDA-approved for BED, but it has limitations:

• As a controlled stimulant, it’s harder to access via telehealth
• It has abuse potential and is more tightly regulated
• It may not be appropriate for patients with certain conditions
• Insurance coverage can be challenging
• Cost is often significantly higher

Topiramate and bupropion offer accessible, well-studied alternatives that many patients tolerate well.

Your Right to Informed Consent

When a provider recommends off-label medication, they should:

• Clearly explain that the use is off-label
• Discuss the evidence supporting this use
• Present alternatives (including on-label options)
• Explain risks and benefits
• Obtain your documented consent

Don’t hesitate to ask questions. A good provider welcomes the opportunity to explain their clinical reasoning.

What About Prescription Monitoring Programs?

Many patients wonder whether their BED medication will be tracked in state prescription monitoring programs (PMPs, also called PDMPs).

The Short Answer

For topiramate and bupropion, most states do not require PMP checks because they’re not controlled substances. PMP databases primarily track Schedule II-V controlled medications (stimulants, opioids, benzodiazepines, etc.).

Why Your Provider Might Check Anyway

Even though not legally required for these medications, responsible providers might review:

• Your medication history to check for potential drug interactions
• Whether you’re already on another bupropion product (to avoid duplication)
• Other medications that might affect seizure threshold

This is good clinical practice, not a sign of suspicion or distrust.

Privacy Considerations

PMP data is confidential and protected under both state and federal privacy laws. Only authorized healthcare providers and certain regulatory/law enforcement officials can access it, and only for specific legitimate purposes.

Refills, Follow-Up, and Long-Term Management

Starting medication for BED is just the beginning. Here’s what ongoing treatment typically looks like:

Initial Monitoring Period (First 1-3 Months)

Week 2-4: First follow-up appointment

• Assess tolerability and any side effects
• Discuss early changes in binge frequency or intensity
• May adjust dose if needed

Month 2-3: Second follow-up

• Evaluate effectiveness at current dose
• Consider titration (especially with topiramate, which is usually started low and increased gradually)
• Assess whether additional support (therapy, nutrition counseling) is needed

Maintenance Phase (After 3 Months)

If medication is helpful, you’ll typically transition to:

• Follow-up appointments every 1-3 months
• Regular assessment of binge frequency, weight, mood, and quality of life
• Periodic medication review to determine if you still need it or if dosage should change
• Coordination with therapy and other treatments

Prescription Refills

Because these are non-controlled medications, providers can typically authorize refills for extended periods (often up to 11 months, depending on state law). This means you won’t necessarily need a new prescription every month.

However, you should still have regular appointments to monitor your progress. Some states (like Alabama, Georgia, and New Hampshire) have specific rules requiring periodic in-person or telehealth follow-ups for ongoing prescriptions.

What If the Medication Doesn’t Work?

Not everyone responds to the same medication. If after 2-3 months at an adequate dose you’re not seeing improvement, your provider might:

• Switch to the alternative medication (if you tried bupropion, try topiramate, or vice versa)
• Adjust the dose
• Add psychotherapy if you’re not already engaged in it
• Consider referral to an eating disorder specialist for more intensive treatment
• In some cases, discuss whether an in-person evaluation for Vyvanse or other options makes sense

Combining Medication with Therapy: The Gold Standard

While this guide focuses on medication access via telehealth, it’s important to emphasize that comprehensive BED treatment almost always includes therapy.

Why Therapy Matters

Medication can help reduce the biological drive to binge and improve impulse control, but it doesn’t address:

• The emotional triggers for binge eating
• Underlying trauma or stress
• Distorted beliefs about food, weight, and body image
• Lack of coping skills for difficult emotions
• Practical strategies for meal planning and eating patterns

Evidence-Based Therapies for BED

Cognitive Behavioral Therapy (CBT) – The most studied and effective therapy for BED, focusing on changing thought patterns and behaviors around food

Dialectical Behavior Therapy (DBT) – Particularly helpful if emotional dysregulation drives binge eating

Interpersonal Therapy (IPT) – Addresses relationship issues that may trigger binge episodes

Telehealth for Therapy Too

The good news? Just as medication can be prescribed via telehealth, therapy for BED can also be delivered virtually with excellent outcomes. Many patients find it helpful to work with both a prescriber for medication management and a therapist for weekly sessions.

Klarity can help coordinate this comprehensive approach, connecting you with both medication providers and therapists who specialize in eating disorders.

Insurance Coverage and Costs

Does Insurance Cover Telehealth BED Treatment?

Most insurance plans now cover telehealth visits at the same rate as in-person appointments, thanks to policies implemented during the pandemic and largely maintained afterward.

For the visit itself: Check with your insurance to confirm telehealth parity. Most major insurers (including Aetna, Cigna, Blue Cross Blue Shield, UnitedHealthcare, etc.) cover telehealth mental health and medical appointments.

For medications: Coverage varies significantly:

• Generic bupropion is usually well-covered with low copays
• Topiramate is also typically covered as a generic
• If your provider prescribes brand-name versions (like Wellbutrin XL), your copay may be higher

Cash-Pay Options

If you’re paying out of pocket:

• Telehealth visits often cost $150-300 for an initial consultation and $75-150 for follow-ups (Klarity offers competitive transparent pricing)
• Generic bupropion typically costs $10-40 per month at most pharmacies
• Generic topiramate usually costs $15-50 per month
• GoodRx and similar discount programs can reduce medication costs significantly

This can be significantly more affordable than in-person specialist visits, which often cost $300-500+ for initial consultations and aren’t always covered by insurance.

Recent Regulatory Developments (2025-2026)

The telehealth regulatory landscape continues to evolve. Here are the most recent developments that affect BED treatment:

Federal Updates

December 2025: DEA extended the COVID-era telehealth prescribing flexibilities for controlled substances through December 31, 2026. This is the fourth extension, giving Congress and the DEA more time to develop permanent rules.

Takeaway: While this primarily affects controlled substance prescribing (like ADHD medications), it signals continued federal support for telehealth access. Non-controlled BED medications remain unaffected and fully accessible.

State Legislative Changes

New Hampshire (August 2025): Passed legislation (SB 252) explicitly allowing telehealth prescribing of Schedule II-IV controlled substances, with annual in-person follow-up required. This removed barriers to ADHD and other mental health medication access.

New York (May 2025): Implemented final rules requiring in-person examination before prescribing controlled substances once federal waivers expire. However, non-controlled medications (like those for BED) are explicitly exempt.

Wisconsin (August 2025): Enacted the APRN Modernization Act, granting nurse practitioners full practice authority. This expands the pool of providers who can independently prescribe BED medications via telehealth.

Michigan (2025): Joined full-practice states for NPs through implementation of 2023 legislation, effective in 2025.

Delaware (July 2025): SB 101 clarified that telemedicine is permissible for medication-assisted treatment for opioid use disorder, resolving conflicts in prior law. While not BED-specific, this demonstrates continued state support for telehealth prescribing.

What’s Next?

Watch for: DEA’s permanent rule on telehealth prescribing (expected before the end of 2026). While unlikely to affect non-controlled medications, this will determine long-term access to controlled medications like Vyvanse.

State legislation: Several states (including Alabama and South Carolina) have considered expanding NP scope of practice. If passed, these changes would further increase provider availability for telehealth BED treatment.

Taking the Next Step: How to Get Started

If you’re ready to explore telehealth treatment for binge eating disorder:

1. Assess Your Readiness

• Reflect on your binge eating patterns and how they affect your life
• Consider whether you’re ready to commit to treatment (including follow-up appointments)
• Think about what barriers have prevented you from seeking help before

2. Research Providers

• Look for telehealth platforms with specialized experience in eating disorders or mental health
• Verify that providers are licensed in your state
• Read reviews and check credentials
• Confirm pricing and insurance acceptance

3. Prepare for Your Appointment

• Write down your binge eating history (frequency, triggers, typical episodes)
• List all current medications and supplements
• Note any previous mental health diagnoses or treatments
• Prepare questions for your provider

4. Schedule Your Evaluation

• Book an initial consultation
• Ensure you have a private space with good internet for your video appointment
• Plan for 30-45 minutes of uninterrupted time

5. Follow Through

• Attend all scheduled follow-up appointments
• Track your progress (binge frequency, mood, side effects)
• Be honest with your provider about what’s working and what isn’t
• Consider adding therapy if you haven’t already

Klarity Health makes this process simple: Visit our website, answer a brief questionnaire, and we’ll match you with a provider who can usually see you within 24-48 hours. Our platform handles scheduling, insurance verification, and prescription transmission to your pharmacy—all designed to remove obstacles between you and treatment.

Frequently Asked Questions

Q: Is telehealth treatment for BED as effective as in-person treatment?

A: Research shows that telehealth can be just as effective as in-person care for many mental health conditions, including eating disorders. The key is comprehensive assessment, appropriate medication selection, regular follow-up, and integration with therapy.

Q: How long does it take for medication to work for BED?

A: Most patients begin noticing some reduction in binge frequency within 4-8 weeks, though full effects may take 2-3 months. Your provider will work with you to find the optimal dose.

Q: Can I get medication without doing therapy?

A: Technically yes—providers can prescribe medication without requiring simultaneous therapy. However, research strongly suggests that combining medication with therapy produces the best outcomes. Most ethical providers will at least strongly recommend therapy.

Q: What if I live in a rural area with no specialists?

A: This is exactly where telehealth shines. You can connect with BED specialists regardless of your geographic location, as long as they’re licensed in your state.

Q: Will my employer or family know I’m getting treatment?

A: Telehealth visits are confidential and protected by HIPAA. Your insurance EOB (Explanation of Benefits) may show a claim for a telehealth visit, but specific details about your diagnosis are not disclosed. If you pay out-of-pocket, there’s no insurance trail.

Q: Can I use telehealth if I’m currently in therapy in person?

A: Absolutely. Many patients see a therapist in person for weekly CBT while managing medication through a telehealth prescriber. This can be an excellent combination, and good providers will coordinate care.

Q: What happens if I move to another state?

A: You’ll need to transition to a provider licensed in your new state. Klarity operates in multiple states, so we may be able to continue your care with a different provider in our network.

Conclusion: Access to Help Is Real and Available

If you’ve been struggling with binge eating disorder, feeling isolated or ashamed, unsure where to turn—please know that effective, legitimate, accessible treatment is available through telehealth in 2026.

The regulatory framework has matured since the pandemic’s early days. Federal and state laws now support safe, comprehensive telehealth care for BED using evidence-based medications like topiramate and bupropion. These non-controlled medications can be prescribed via video appointment without the barriers that affect controlled substances.

You don’t need to wait months for a specialist appointment. You don’t need to drive hours to the nearest eating disorder clinic. You don’t need to sit in a waiting room feeling judged. You can get help from home, often within days of deciding you’re ready.

The path forward involves:

• A thorough evaluation with a licensed provider
• Development of a personalized treatment plan
• Access to medication when appropriate
• Integration with therapy and other supports
• Ongoing monitoring and adjustment

At Klarity Health, we’re committed to making this path as smooth as possible—with available providers, transparent pricing, and comprehensive care that treats you as a whole person, not just a prescription.

Binge eating disorder is a real medical condition. It’s not a lack of willpower or a character flaw. It responds to treatment. And that treatment is now more accessible than ever before.

Ready to take the first step? Klarity Health can connect you with a licensed provider in your state who specializes in eating disorder treatment. With both insurance and cash-pay options, same-day appointments often available, and a platform designed for your privacy and convenience, there’s never been a better time to seek help.

You deserve support. You deserve recovery. And you deserve access to care that fits your life.

Research Currency Statement & Citations

Verified as of: January 4, 2026

This article is based on the most current available information regarding federal and state telehealth regulations, medication safety data, and clinical practice guidelines. Key regulatory sources have been verified through December 2025 and January 2026, with approximately 80% of sources dating from 2025 or updated to reflect 2025 changes.

Top 5 Primary Citations:

1. U.S. Department of Health and Human Services (January 2, 2026). ‘DEA Extends Telemedicine Prescribing Flexibilities Through December 31, 2026.’ HHS Press Release. Available at: www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Health Law Blog (August 2025). ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Legal analysis with state-by-state regulatory breakdown. Available at: www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits

3. Center for Connected Health Policy (November-December 2025). ‘State Telehealth Laws & Reimbursement Policies: Online Prescribing Requirements.’ CCHP State Law Database. Available at: www.cchpca.org/topic/online-prescribing/

4. Health Jobs Nationwide Blog (2025). ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ Nurse practitioner scope of practice analysis. Available at: blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025

5. U.S. National Library of Medicine – DailyMed (Latest FDA Label Revision). ‘Bupropion Hydrochloride Extended-Release Tablets – Full Prescribing Information.’ FDA-approved drug labeling with contraindications and warnings. Available at: dailymed.nlm.nih.gov

Note on Temporary Regulations: DEA telehealth rules for controlled substances remain temporary and are currently extended through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to Ryan Haight Act restrictions. State-level information reflects late 2025 verification, with some states (Alabama, South Carolina) flagged for ongoing legislative changes to NP scope that have not yet been finalized.

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12